Home » Topics » BioWorld Science

BioWorld Science
RSS

ADAMTS13 deficiency contributes to Alzheimer's disease cerebrovascular dysfunction

July 4, 2019

Protein provides protection against diabetic retinopathy

July 4, 2019

Sirona's SGLT2 inhibitor TFC-039 advancing through phase I trials

July 4, 2019

Phase III trial of tucidinostat/exemestane in advanced, HR-positive breast cancer

July 4, 2019

Clinical qualification of a novel P2X7-specific PET ligand in healthy volunteers

July 4, 2019

Their antiviral work done, T cells go rogue

July 4, 2019

Algernon's NP-120 reduces fibrosis in in vivo animal model study of IPF

July 3, 2019

European Commission approves Dovato for HIV-1 infection

July 3, 2019

Tracon advances phase I/II trial of androgen receptor antagonist TRC-253 in metastatic CRPC

July 3, 2019

Phase III MINISTONE-2 study of Xofluza in children with influenza meets primary endpoint

July 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...